PLGA-mPEG, MW x 2K, n 2K provides a biodegradable amphiphilic block copolymer for nanoparticle formulation and drug delivery research and specifically combines a 2 kDa poly(lactic-co-glycolic acid) (PLGA) block with a 2 kDa methoxy polyethylene glycol (mPEG) chain. Its equal block molecular weights support polymer self-assembly, hydrophobic drug encapsulation studies, and nanoparticle surface hydration.
Key Features and Benefits
- 2 kDa PLGA Block: Provides a short biodegradable hydrophobic polyester segment for polymer self-assembly, drug encapsulation, and controlled-release formulation research.
- 2 kDa mPEG Block: Introduces a hydrophilic PEG chain that contributes to aqueous compatibility, nanoparticle surface hydration, and dispersion properties.
- Amphiphilic Structure: Combines hydrophobic PLGA and hydrophilic mPEG segments to specifically support polymeric self-assembly under suitable formulation conditions.
- Biodegradable Backbone: Contains hydrolytically degradable ester bonds that support investigations of polymer degradation, matrix erosion, and drug release behavior.
- Equal Block Molecular Weights: Features a nominal 1:1 PLGA-to-mPEG molecular weight ratio, providing approximately 50% PEG by combined block mass.
- Methoxy-Terminated PEG: Incorporates a methyl ether terminus without a dedicated reactive conjugation group, supporting preparation of PEG-containing polymeric materials.
- Hydrophilic Surface Functionality: Provides PEG chains that may influence nanoparticle hydration, protein interactions, aggregation, and colloidal stability.
- Controlled-Release Potential: Supports biodegradable polymer formulations specifically for evaluating drug diffusion, polymer hydrolysis, and release behavior.
- Formulation Versatility: Accommodates nanoprecipitation, solvent exchange, and emulsification methods for investigating polymeric nanoparticles and other self-assembled structures.
Applications
- Polymeric Nanoparticle Development: Supports preparation and characterization of biodegradable nanocarriers containing hydrophobic PLGA domains and hydrophilic mPEG segments.
- Polymeric Micelle Research: Enables investigation of amphiphilic polymer self-assembly, micelle formation, and aggregation under suitable aqueous conditions.
- Hydrophobic Drug Encapsulation: Supports evaluation of compatible, poorly water-soluble compounds within PLGA-containing polymeric formulations.
- Controlled Drug Release: Facilitates studies of drug diffusion, polymer degradation, and release kinetics in biodegradable delivery systems.
- Drug Delivery Research: Supports development of amphiphilic polymer carriers for encapsulating and delivering compatible therapeutic research compounds.
- Nanoparticle Surface Engineering: Enables evaluation of PEG-containing surfaces and their effects on hydration, protein interactions, and colloidal stability.
- Polymer Degradation Studies: Supports characterization of PLGA hydrolysis, molecular weight reduction, and degradation-dependent drug release behavior.
- Biodegradable Biomaterials: Provides an amphiphilic polymer building block for developing experimental biodegradable materials and evaluating their properties.
- Polymer Composition Research: Supports comparisons of PLGA-to-PEG ratios and their effects on self-assembly, drug loading, and formulation stability.
Storage and Handling
- Storage: Store at −20°C in a dry, tightly sealed container, protected from moisture and excessive heat. Follow product-specific storage instructions when available. Minimize humidity exposure to reduce premature PLGA hydrolysis.
- Handling: Handle using clean, dry equipment and dissolve in a compatible solvent, such as acetone, DMF, DMSO, or dichloromethane. Confirm solubility before selecting the formulation method.
- Prepare polymeric nanoparticles or micelles through nanoprecipitation, solvent exchange, or emulsification, depending on the desired formulation characteristics. The nominal 1:1 PLGA-to-mPEG ratio provides approximately 50% PEG by combined block mass. This balanced composition may influence polymer self-assembly, drug loading, and aqueous dispersion behavior.
- Evaluate particle size, aggregation, drug loading, and release characteristics using suitable analytical techniques. The relatively short PLGA block may affect hydrophobic core formation and encapsulation capacity. Avoid prolonged exposure to moisture, strong acids, and alkaline conditions. Confirm the PLGA lactide-to-glycolide ratio and polymer specifications before use.
PLGA-mPEG, MW x 2K, n 2K combines short biodegradable PLGA and hydrophilic mPEG blocks for polymeric nanoparticle research and specifically supports polymeric self-assembly, micelle development, drug encapsulation studies, controlled-release research, and biodegradable biomaterials development.
AxisPharm offers 5000+ PEG Linkers with high purity. Different kinds of PEG Reagents may be available by custom synthesis.